Paper41245430
Topical losartan for established corneal fibrosis with machine learning-based predictors.
Domene-Hickman JL and 6 others. Ther Adv Ophthalmol, 2025. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Topical losartan for established corneal fibrosis with machine learning-based predictors. Papers, record 41245430. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41245430
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Topical losartan for established corneal fibrosis with machine learning-based predictors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39133495 | Effect of Topical Losartan in the Treatment of Established Corneal Fibrosis in Rabbits. | Transl Vis Sci Technol | 2024 | https://conductscience.org/library/papers/39133495 | PubMed |
| 2 | 36963570 | Global Trends in Blindness and Vision Impairment Resulting from Corneal Opacity 1984-2020: A Meta-analysis. | Ophthalmology | 2023 | https://conductscience.org/library/papers/36963570 | PubMed |
| 3 | 26633035 | Global Survey of Corneal Transplantation and Eye Banking. | JAMA Ophthalmol | 2016 | https://conductscience.org/library/papers/26633035 | PubMed |
| 4 | 35819289 | Topical Losartan and Corticosteroid Additively Inhibit Corneal Stromal Myofibroblast Generation and Scarring Fibrosis After Alkali Burn Injury. | Transl Vis Sci Technol | 2022 | https://conductscience.org/library/papers/35819289 | PubMed |
| 5 | 36367262 | Topical Losartan for Treating Corneal Fibrosis (Haze): First Clinical Experience. | J Refract Surg | 2022 | https://conductscience.org/library/papers/36367262 | PubMed |
| 6 | 36476304 | Losartan Inhibition of Myofibroblast Generation and Late Haze (Scarring Fibrosis) After PRK in Rabbits. | J Refract Surg | 2022 | https://conductscience.org/library/papers/36476304 | PubMed |
| 7 | 38986874 | Corneal Opacity in the United States: An American Academy of Ophthalmology IRIS® Registry (Intelligent Research in Sight) Study. | Ophthalmology | 2025 | https://conductscience.org/library/papers/38986874 | PubMed |
| 8 | 39671090 | Topical Losartan for Corneal Fibrosis: A Case Series With Densitometry Analysis. | Cornea | 2026 | https://conductscience.org/library/papers/39671090 | PubMed |
| 9 | 38589814 | Methods of determining optimal cut-point of diagnostic biomarkers with application of clinical data in ROC analysis: an update review. | BMC Med Res Methodol | 2024 | https://conductscience.org/library/papers/38589814 | PubMed |
| 10 | 37750746 | Topical Losartan Decreases Myofibroblast Generation But Not Corneal Opacity After Surface Blast-Simulating Irregular PTK in Rabbits. | Transl Vis Sci Technol | 2023 | https://conductscience.org/library/papers/37750746 | PubMed |
| 11 | 11171784 | Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy. | Circulation | 2001 | https://conductscience.org/library/papers/11171784 | PubMed |
| 12 | 37899510 | Optimum pinhole size determination in pinhole pupilloplasty for higher-order aberrations. | J Cataract Refract Surg | 2024 | https://conductscience.org/library/papers/37899510 | PubMed |
| 13 | 38570181 | Two-phase mechanism in the treatment of corneal stromal fibrosis with topical losartan. | Exp Eye Res | 2024 | https://conductscience.org/library/papers/38570181 | PubMed |
| 14 | 12470966 | TGFbeta induced myofibroblast differentiation of rabbit keratocytes requires synergistic TGFbeta, PDGF and integrin signaling. | Exp Eye Res | 2002 | https://conductscience.org/library/papers/12470966 | PubMed |
| 15 | 32564810 | Lighting a Pathway: The Minority Ophthalmology Mentoring Program. | Ophthalmology | 2020 | https://conductscience.org/library/papers/32564810 | PubMed |
| 16 | 35316964 | Machine learning models and over-fitting considerations. | World J Gastroenterol | 2022 | https://conductscience.org/library/papers/35316964 | PubMed |
| 17 | 33263285 | TGFβ1 and TGFβ2 proteins in corneas with and without stromal fibrosis: Delayed regeneration of apical epithelial growth factor barrier and the epithelial basement membrane in corneas with stromal fibrosis. | Exp Eye Res | 2021 | https://conductscience.org/library/papers/33263285 | PubMed |
| 18 | 35523917 | Demystifying the Black Box: The Importance of Interpretability of Predictive Models in Neurocritical Care. | Neurocrit Care | 2022 | https://conductscience.org/library/papers/35523917 | PubMed |
| 19 | 11285665 | Corneal blindness: a global perspective. | Bull World Health Organ | 2001 | https://conductscience.org/library/papers/11285665 | PubMed |
| 20 | 37856135 | Diverse Research Teams and Underrepresented Groups in Clinical Studies. | JAMA Ophthalmol | 2023 | https://conductscience.org/library/papers/37856135 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 41753041 | Topical Losartan in Ophthalmology: Rationale, Experimental and Clinical Evidence, and Emerging Clinical Applications. | J Clin Med | 2026 | https://conductscience.org/library/papers/41753041 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41245430
GET https://conductscience.org/api/papers/v1/41245430/references?page=2